Fresenius Medical Care vs Kymera Therapeutics
Fresenius Medical Care (FMS), health care, and Kymera Therapeutics (KYMR), health care, side by side on market value, valuation, margins, balance sheet and price change. Higher and lower are marked; neither is called better.
Fresenius Medical Care is worth $11.3B on the stock market and Kymera Therapeutics $10.4B: Fresenius Medical Care is valued at 9% more. Fresenius Medical Care's operating margin in its latest fiscal year was 9.31% and Kymera Therapeutics's -891%. Over the past year Fresenius Medical Care's share price has moved -4.75% and Kymera Therapeutics's +95.7%.
Key facts
- Fresenius Medical Care market value
- $11.3B
- Kymera Therapeutics market value
- $10.4B
- Fresenius Medical Care P/E
- 12.5
- Fresenius Medical Care revenue
- $21.8BFY to 2025-12-31
- Kymera Therapeutics revenue
- $39.2MFY to 2025-12-31
- Superinvestors holding both
- 0
Market values as of .
| Measure | Fresenius Medical Care | Kymera Therapeutics |
|---|---|---|
| Sector | Health Care | Health Care |
| Country | ||
| Fiscal year ends | 2025-12-31 | 2025-12-31 |
| Size | ||
| Market cap | $11.3Bhigher | $10.4Blower |
| Revenue | $21.8Bhigher | $39.2Mlower |
| Earnings | $1.1Bhigher | -$311.4Mlower |
| Employees | 106,291higher | 285lower |
| Total assets | $34.4Bhigher | $1.7Blower |
| Valuation | ||
| P/E | 12.5 | — |
| P/S | 0.5lower | 265higher |
| P/B | — | 6.4 |
| Dividend yield | — | 0.00% |
| Profitability | ||
| Operating margin | 9.31%higher | -891%lower |
| Balance sheet | ||
| Net assets | $14.8Bhigher | $1.6Blower |
| Total liabilities | $18.6Bhigher | $163.1Mlower |
| Total debt | $12B | — |
| Cash on hand | $1.8Bhigher | $357Mlower |
| Price change | ||
| Today | -0.78%higher | -3.44%lower |
| 1 year | -4.75%lower | +95.7%higher |
Market value, P/E, P/B, dividend yield and price changes are from live quotes (Yahoo Finance; prices may be delayed 15 minutes or more). Revenue, earnings, operating margin and the balance-sheet figures are from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day. P/S sets today's market value against the latest fiscal year's revenue. “Higher” and “lower” compare the two numbers only; a higher P/E or more debt is not better. Dividend yield and P/B are shown only for companies based in the US. A dash means no figure is on file.
Which superinvestors hold them
From each tracked investor's latest 13F filing. A 13F lists long positions in US-listed shares at a quarter end, filed up to 45 days later.
Both (0)
None of the tracked investors.
Fresenius Medical Care only (3)
Kymera Therapeutics only (1)
Percentages are each holding's share of that investor's reported portfolio. Who owns FMS · Who owns KYMR
More on Fresenius Medical Care
Further comparisons
Fresenius Medical Care against its closest peers
Kymera Therapeutics against its closest peers
Learn
Questions and answers
Which is bigger, Fresenius Medical Care or Kymera Therapeutics?
By market value, Fresenius Medical Care is the larger: $11.3B against $10.4B for Kymera Therapeutics. By revenue in its latest fiscal year, Fresenius Medical Care is the larger: $21.8B against $39.2M for Kymera Therapeutics.
Which has the higher operating margin?
Fresenius Medical Care: 9.31%, against -891% for Kymera Therapeutics. Operating margin is operating income as a share of revenue in the latest fiscal year.
Which superinvestors own both Fresenius Medical Care and Kymera Therapeutics?
None of the tracked superinvestors holds both in their latest 13F filing. 3 hold Fresenius Medical Care and 1 holds Kymera Therapeutics.
Cite this page
Funkfolio, “Fresenius Medical Care vs Kymera Therapeutics”, data as of 18 November 2026. https://funkfolio.com/compare/fms-vs-kymr
Underlying data: Yahoo Finance quotes; SEC annual reports collected 2026-11-12; 13F filings.